Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study).
Arthritis Rheumatol
; 2020 Apr 09.
Article
in En
| MEDLINE
| ID: mdl-32270926
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Arthritis Rheumatol
Year:
2020
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos